Cargando…
Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate
INTRODUCTION: Neuropsychiatric symptoms are important treatment targets in the management of dementia and can be present at very early clinical stages of neurodegenerative diseases. Increased cortisol has been reported in Alzheimer’s disease (AD) and has been associated with faster cognitive decline...
Autores principales: | Ouanes, Sami, Rabl, Miriam, Clark, Christopher, Kirschbaum, Clemens, Popp, Julius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762003/ https://www.ncbi.nlm.nih.gov/pubmed/36529757 http://dx.doi.org/10.1186/s13195-022-01139-9 |
Ejemplares similares
-
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
por: Ouanes, Sami, et al.
Publicado: (2022) -
High Cortisol and the Risk of Dementia and Alzheimer’s Disease: A Review of the Literature
por: Ouanes, Sami, et al.
Publicado: (2019) -
Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer’s Disease
por: Mroczek, Magdalena, et al.
Publicado: (2022) -
Dehydroepiandrosterone sulfate and dehydroepiandrosterone sulfate/cortisol ratio in cirrhotic patients with septic shock: another sign of hepatoadrenal syndrome?
por: Tsai, Ming-Hung, et al.
Publicado: (2017) -
Diagnostic Accuracy of Dehydroepiandrosterone Sulfate and Corticotropin in Autonomous Cortisol Secretion
por: Carafone, Lindsay E., et al.
Publicado: (2021)